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failure, little is known about the role of L-carnitine in the right ven-
tricular failure in pulmonary arterial hypertension.
METHODS Experimental pulmonary hypertension develops in male
Sprague-Dawley rats subjected to a single subcutaneous injection of
monocrotaline (60 mg kg-1, MCT group). Compared with the vehicle
group, by day 21, MCT group developed higher right ventricular
systolic pressure (345 mmHg versus 194 mmHg; P<0.001)
and right ventricular hypertrophy (0.510.13 versus 0.280.05;
P<0.001). In MCT group, L-carnitine levels were signiﬁcantly
decreased in both the right ventricular myocardium (15947 nmol/g
vs 43576 nmol/g, P<0.05) and plasma (73 umol/l vs 1610 umol/
l, P<0.05), indicating L-carnitine deﬁciency was associated with the
right ventricular failure. To evaluate whether supplementation with
L-carnitine could attenuate right ventricular failure, we treat the
rats received monocrotaline with either L-carnitine (500mg kg-1
day-1, L-carnitine MCT group) or saline (saline MCT group) for
14 days.
RESULTS In comparison with saline MCT group, the mean pulmonary
arterial pressure and the right ventricular systolic pressure decreased
by 34% (P¼0.04) and 25% (P¼0.01) in the L-carnitine MCT group,
respectively. The right ventricular hypertrophy index and right ven-
tricular free wall thickness decreased by 25% (P¼0.02) and 14%
(P¼0.03) in the L-carnitine MCT group, respectively. Furthermore, the
myocardial PET/ CT demonstrated that SUVRV / LV of L-carnitine MCT
group reduced by 15% when compared with saline MCT group
(P<0.05).
CONCLUSIONS The L-carnitine deﬁciency may aggravate develop-
ment of pulmonary hypertension. Supplementation with L-carnitine
could improve pulmonary arterial hypertension by reversing energy
metabolism dysfunction of right ventricular failure.GW26-e1573
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OBJECTIVES Growing evidence has shown that apelin/APJ system
functions as a critical mediator of cardiac development as well as
cardiovascular function. Here we investigated the role of apelin in the
cardiomyogenic differentiation of mesenchymal stem cells derived
from Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) and
undescribed functional link between MAPK/ERK signaling cascade
and apelin/APJ axis in vitro.
METHODS We used RNA interference methodology and gene trans-
fection technique to regulate the expression of apelin in WJ-MSCs,
which were divided into four groups: (A) WJ-MSCs; (B) apelin-silenced
WJ-MSCs; (C) apelin-regained WJ-MSCs and the control group. All
groups were treated with an effective cardiac differentiation protocol
including 5-azacytidine and bFGF, except the control group. Cells
were analyzed by real-time RT-PCR, Western blot, Immunoﬂuores-
cence and Calcium ﬂux assay. MEK1/2 inhibitor PD0325901 and MEK5
inhibitor BIX02189 were used to regulated ERK1/2 and ERK5 in apelin-
silenced WJ-MSCs with/without supplementary apelin-13 during
Cardiomyogenic Differentiation.
RESULTS Four weeks after induction, cells in group A and C assumed
a stick-like morphology and myotube-like structures except apelin-
silenced cells and the control group. The silencing of apelin decreased
the expressions of several critical cardiac progenitor transcription
factors (Mesp1, Mef2c, NKX2.5) and cardiac phenotypes (cardiac a-
actin, b-MHC, cTnT and connexin-43). Meanwhile, endogenous
compensation of apelin contributed to differentiating into cells with
characteristics of cardiomyocytes in vitro. Remarkably, our experi-
ment indicated that apelin up-regulated cardiac speciﬁc genes in
Wharton’s jelly-derived mesenchymal stem cells via activating ERK1/2
and ERK5.
CONCLUSIONS Our study indicated that apelin was essential for
cardiomyogenic differentiation of WJ-MSCs via activating MEK1/2-
ERK1/2 and MEK5-ERK5, which were involved in MAPK signaling
pathway. Down-regulation of apelin in WJ-MSCs decreases the
expression of several critical cardiac progenitor transcription factors
and cardiac phenotypes.GW26-e2239
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OBJECTIVES Liqihuoxue pills (LQHX) is a compound Miao medicine
in China used for treatment of cardiovascular diseases, and can
decrease acute myocardial infarct and refusion injury in cat and rat.
This study was to investigate whether LQHX ameliorates atrial ﬁbril-
lation by prevention atrial ﬁbrosis in the isoproterenol- induced
myocardial infarct in rats. his study was to investigate whether LQHX
ameliorates atrial ﬁbrillation by prevention atrial ﬁbrosis in the
isoproterenol- induced myocardial infarct in rats.
METHODS Myocardial infarct (MI) rat model was induced by subcutane-
ous injection of 120mg/kg/d isoproterenol for 2 days.We studied a normal
control group and 4 groups of rats undergoing isoproterenol-inducedMI 1
week prior to treatment: isoproterenol (ISO) group, and ISO combined
with LQHX (ISOþLQHX) group. The three ISOþLQHX groups were
administered LQHX (187.5 mg/Kg, 75 mg/Kg, 37.5mg/Kg respectively) by
gavage for 4weeks after 7d for ISO treatment. After treatment for 4weeks,
cardiac function were measured by echocardiography and the histopath-
ological changes of cardiac tissue was observed via Masson’s staining. AF
inducibility and duration were detected by transesophageal programmed
electrical stimulation AF inducing technology. The atrial conduction ve-
locity was detected by multi-electrodes arrays measurements. The
expression of typeI and III collagen and the changes of transforming
growth factor b1 (TGF-b1) in left atrial were detected by western blot.
RESULTS LQHX (at the dose of 37.5 mg/Kg) signiﬁcantly improved left
systolic functions, resulting in improved LV ejection fraction
(64.64.42% vs 57.95.66%; P<0.05), LV internal dimension in systole
(4.740.51 mm vs 5.730.48 mm; P <0.01). LQHX-treated rats had
lower rates of AF inducibility (70%, 56%, 50% inLQHXgroups vs. 90% in
ISO group), and shorter AF duration.Masson’s trichrome staining in ISO
treated group reveals increased left atrial ﬁbrosis (63.45.8%), while
treatment with LQHX resulted in reversal of atrial ﬁbrosis, and in the
lower dose of LQHX group (37.5 mg/Kg) could decreased the left atrial
ﬁbrosis areas to (15.32.4)%. LQHX (at the dose of 75 mg/Kg and 37.5
mg/Kg) also obviously reduced the expression of type I and III collagen
in left atrium and markedly inhibited TGF-b1 protein expression.
CONCLUSIONS LQHX pills reduced the AF inducibility rate and
duration after ISO induced myocardial infarct by inhibiting left atrial
ﬁbrosis, and associate with inhibition typeIand III collagen and TGF-
b1 protein expression in left atrium of rat heart. It obviously suggests
that LQHX could be an effective Chinese drug for the prevention atrial
ﬁbrillation induced by post-MI myocardial remodeling.
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OBJECTIVES The aim of our study was to investigate the roles of
renal sympathetic nerve stimulation (RSS) on atrial ﬁbrillation (AF)
and cardiac autonomic nervous activity.
METHODS RSS was performed using electrical stimulation on the left
renal artery at the 30 volts for 3 hours. Twenty-eight dogs were
randomly assigned to the proximal renal sympathetic stimulation
(RSS) group (P-RSS, N¼7), middle RSS group (M-RSS, N¼7), distal RSS
group (D-RSS, N¼7), and the control group ( sham RSS, N¼7). Effective
refractory period (ERP) and the window of vulnerability (WOV) were
measured. SLGP and LSG function were determined. Neural activities
were recorded from the SLGP and LSG. C-fos and nerve growth factor
(NGF) protein expressing in the SLGP and LSG were examined. Serum
inﬂammatory cytokines were assayed.
RESULTS
(1) Only P-RSS caused pronounced blood pressure rises, induced a sig-
niﬁcant decrease in ERP, and generated a marked increase in WOV
and ERP Dispersion (all P < 0.05).
(2) P-RSS signiﬁcantly facilitated SLGP and LSG function.
(3) The frequency and amplitude of the neural activity in the SLGP and
LSG were markedly increased by P-RSS.
